| Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. | |
| | |
MedLine Citation:
|
PMID: 22473055 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Deep brain stimulation (DBS) to the nucleus accumbens (NAcc-DBS) was associated with antidepressant, anxiolytic, and procognitive effects in a small sample of patients suffering from treatment-resistant depression (TRD), followed over 1 year. Results of long-term follow-up of up to 4 years of NAcc-DBS are described in a group of 11 patients. Clinical effects, quality of life (QoL), cognition, and safety are reported. Eleven patients were stimulated with DBS bilateral to the NAcc. Main outcome measures were clinical effect (Hamilton Depression Rating Scale, Montgomery-Asperg Rating Scale of Depression, and Hamilton Anxiety Scale) QoL (SF-36), cognition and safety at baseline, 12 months (n=11), 24 months (n=10), and last follow-up (maximum 4 years, n=5). Analyses were performed in an intent-to-treat method with last observation carried forward, thus 11 patients contributed to each point in time. In all, 5 of 11 patients (45%) were classified as responders after 12 months and remained sustained responders without worsening of symptoms until last follow-up after 4 years. Both ratings of depression and anxiety were significantly reduced in the sample as a whole from first month of NAcc-DBS on. All patients improved in QoL measures. One non-responder committed suicide. No severe adverse events related to parameter change were reported. First-time, preliminary long-term data on NAcc-DBS have demonstrated a stable antidepressant and anxiolytic effect and an amelioration of QoL in this small sample of patients suffering from TRD. None of the responders of first year relapsed during the observational period (up to 4 years). |
| | |
Authors:
|
Bettina H Bewernick; Sarah Kayser; Volker Sturm; Thomas E Schlaepfer |
Related Documents
:
|
22452755 - An investigation of experiential avoidance, emotion dysregulation, and distress toleran... 22510175 - Impact of regional and local anaesthetics on length of stay in knee arthroplasty. 22295255 - Can classification tree analyses help improve decision making about treatments for depr... 22909285 - Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practi... 21392945 - Factors determining social distance toward people with depression among community pharm... 12885095 - Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a... |
Publication Detail:
|
Type: Journal Article Date: 2012-04-04 |
Journal Detail:
|
Title: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Volume: 37 ISSN: 1740-634X ISO Abbreviation: Neuropsychopharmacology Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-07-18 Completed Date: 2013-03-17 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8904907 Medline TA: Neuropsychopharmacology Country: England |
Other Details:
|
Languages: eng Pagination: 1975-85 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Psychotherapy, University Hospital, Bonn, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Deep Brain Stimulation / methods, trends* Depressive Disorder, Treatment-Resistant / physiopathology, psychology, therapy* Evidence-Based Medicine / instrumentation, methods Female Follow-Up Studies Humans Male Middle Aged Nucleus Accumbens / physiology* Time Factors Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The relationship between mean platelet volume with metabolic syndrome in obese individuals.
Next Document: Aquaporin-4 deficiency impairs synaptic plasticity and associative fear memory in the lateral amygda...